From: Cell therapy in end-stage liver disease: replace and remodel
Cell type | Clinical indication | Clinical application | References |
---|---|---|---|
Hepatocyte | IEM | Yes | |
Crigler–Najjar syndrome type I | Yes | [36] | |
ALF | Yes | ||
ACLF | Yes | ||
PSC | uPA immunodeficient | No | [87] |
Macrophage | Liver fibrosis | Yes | |
MSC | Liver fibrosis, chronic liver disease, ACLF | Yes | |
Haematopoietic progenitor cell | Liver fibrosis | Some clinical reports and small number of randomized trials |